Followers | 308 |
Posts | 73973 |
Boards Moderated | 4 |
Alias Born | 02/16/2008 |

Friday, June 20, 2025 5:32:47 PM
$RITE, 8k
On June 18, 2025, MineralRite Corporation (the “Company”) received written correspondence from the Office of the Chief Accountant of the Division of Corporation Finance of the Securities and Exchange Commission (the “SEC”), granting relief under Rule 3-13 of Regulation S-X. The SEC staff permitted the Company to omit the financial statements of Peeples, Inc., a recently acquired subsidiary, from certain filings otherwise required under Regulation S-X.
This waiver was granted in response to the Company’s requests dated May 21, May 27, and June 2, 2025, and was based on the specific facts and representations made by the Company to the SEC. The waiver allows the Company to proceed with filings that omit the historical financial statements of Peeples, Inc., consistent with the guidance provided by the SEC in its correspondence.
https://ih.advfn.com/stock-market/USOTC/mineralrite-pk-RITE/stock-news/96281441/form-8-k-current-report

Recent RITE News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2025 06:42:20 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 05/30/2025 11:44:14 AM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 05/07/2025 07:39:05 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 04/25/2025 06:54:22 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/04/2025 09:41:37 PM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 02/19/2025 05:59:16 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM